Canandaigua National Trust of Florida’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$435K Sell
1,235
-50
-4% -$17.8K 0.35% 81
2025
Q4
$421K Hold
1,285
0.26% 87
2025
Q3
$363K Sell
1,285
-4
-0.3% -$1.16K 0.29% 82
2025
Q2
$360K Sell
1,289
-28
-2% -$7.93K 0.26% 94
2025
Q1
$410K Sell
1,317
-14
-1% -$4.13K 0.36% 70
2024
Q4
$347K Buy
1,331
+31
+2% +$9.2K 0.27% 86
2024
Q3
$419K Buy
+1,300
New +$425K 0.36% 69

Other funds holding AMGN

Canandaigua National Trust of Florida's AMGN Position: Q1 2026 in Review

Canandaigua National Trust of Florida reduced its Amgen (AMGN) stake by 3.9% in Q1 2026, selling an estimated $17.8K and leaving 1,235 shares worth $435K. The position accounts for 0.35% of the portfolio, ranked #81.

Canandaigua National Trust of Florida first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,135 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Canandaigua National Trust of Florida held 1,235 shares of Amgen worth $435K as of Q1 2026.
  • Canandaigua National Trust of Florida sold 50 Amgen shares in Q1 2026, an estimated $17.8K.
  • Amgen made up 0.35% of Canandaigua National Trust of Florida's portfolio in Q1 2026, its #81 holding.
  • Canandaigua National Trust of Florida first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • 3,135 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.